The Inositide Signaling Pathway As a Target for Treating Gastric Cancer and Colorectal Cancer

被引：11

作者：

Kim, Hong Jun ^{[1
]}

Lee, Suk-young ^{[1
]}

Oh, Sang Cheul ^{[1
]}

机构：

[1] Korea Univ, Coll Med, Dept Internal Med, Div Oncol Hematol, Seoul, South Korea

来源：

FRONTIERS IN PHYSIOLOGY | 2016年 / 7卷

关键词：

phosphoinositide; PI3K; mTOR; Akt; colorectal cancer; gastric cancer; targeted therapy;

D O I：

10.3389/fphys.2016.00168

中图分类号：

Q4 [生理学];

学科分类号：

071003 ;

摘要：

Gastric cancer and colorectal cancer are the leading cause of cancer mortality and have a dismal prognosis. The introduction of biological agents to treat these cancers has resulted in improved outcomes, and combination chemotherapy with targeted agents and conventional chemotherapeutic agents is regarded as standard therapy. Additional newly clarified mechanisms of oncogenesis and resistance to targeted agents require the development of new biologic agents. Aberrant activation of the inositide signaling pathway by a loss of function PTEN mutation or gain of function mutation/amplification of PIK3CA is an oncogenic mechanism in gastric cancer and colorectal cancer. Clinical trials with biologic agents that target the inositide signaling pathway are being performed to further improve treatment outcomes of patients with advanced gastric cancer and metastatic colorectal cancer (CRC). In this review we summarize the inositide signaling pathway, the targeted agents that inhibit abnormal activation of this signaling pathway and the clinical trials currently being performed in patients with advanced or metastatic gastric cancer and metastatic CRC using these targeted agents.

引用

页数：8

共 92 条

[1] mTOR as a therapeutic target in patients with gastric cancer [J].

Al-Batran, Salah-Eddin ;

Ducreux, Michel ;

Ohtsu, Atsushi .

INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (03) :491-496

[2] Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B alpha [J].

Alessi, DR ;

James, SR ;

Downes, CP ;

Holmes, AB ;

Gaffney, PRJ ;

Reese, CB ;

Cohen, P .

CURRENT BIOLOGY, 1997, 7 (04) :261-269

[3] Lgr5+ve Stem Cells Drive Self-Renewal in the Stomach and Build Long-Lived Gastric Units In Vitro [J].

Barker, Nick ;

Huch, Meritxell ;

Kujala, Pekka ;

van de Wetering, Marc ;

Snippert, Hugo J. ;

van Es, Johan H. ;

Sato, Toshiro ;

Stange, Daniel E. ;

Begthel, Harry ;

van den Born, Maaike ;

Danenberg, Esther ;

van den Brink, Stieneke ;

Korving, Jeroen ;

Abo, Arie ;

Peters, Peter J. ;

Wright, Nick ;

Poulsom, Richard ;

Clevers, Hans .

CELL STEM CELL, 2010, 6 (01) :25-36

[4] Phase I, Dose-Escalation Study of BKM120, an Oral Pan-Class I PI3K Inhibitor, in Patients With Advanced Solid Tumors [J].

Bendell, Johanna C. ;

Rodon, Jordi ;

Burris, Howard A. ;

de Jonge, Maja ;

Verweij, Jaap ;

Birle, Diana ;

Demanse, David ;

De Buck, Stefan S. ;

Ru, Qinhua C. ;

Peters, Malte ;

Goldbrunner, Michael ;

Baselga, Jose .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (03) :282-290

[5] The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane [J].

Berndt, N. ;

Yang, H. ;

Trinczek, B. ;

Betzi, S. ;

Zhang, Z. ;

Wu, B. ;

Lawrence, N. J. ;

Pellecchia, M. ;

Schoenbrunn, E. ;

Cheng, J. Q. ;

Sebti, S. M. .

CELL DEATH AND DIFFERENTIATION, 2010, 17 (11) :1795-1804

[6] Phosphoinositide signalling in cancer: beyond PI3K and PTEN [J].

Bunney, Tom D. ;

Katan, Matilda .

NATURE REVIEWS CANCER, 2010, 10 (05) :342-352

[7] The phosphoinositide 3-kinase pathway [J].

Cantley, LC .

SCIENCE, 2002, 296 (5573) :1655-1657

[8] PIK3CA in colorectal cancer [J].

Cathomas, Gieri .

FRONTIERS IN ONCOLOGY, 2014, 4

[9] IDENTIFICATION OF AN 11-KDA FKBP12-RAPAMYCIN-BINDING DOMAIN WITHIN THE 289-KDA FKBP12-RAPAMYCIN-ASSOCIATED PROTEIN AND CHARACTERIZATION OF A CRITICAL SERINE RESIDUE [J].

CHEN, J ;

ZHENG, XF ;

BROWN, EJ ;

SCHREIBER, SL .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (11) :4947-4951

[10] Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP [J].

Choi, JW ;

Chen, J ;

Schreiber, SL ;

Clardy, J .

SCIENCE, 1996, 273 (5272) :239-242

← 1 2 3 4 5 6 7 8 9 10 →